down arrow

Amphastar Pharmaceuticals, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US03209R1032
USD
26.60
0.1 (0.38%)

Dec 19

NAS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Amicus Therapeutics, Inc.
Madrigal Pharmaceuticals, Inc.
Prestige Consumer Healthcare, Inc.
Corcept Therapeutics, Inc.
Cytokinetics, Inc.
Ultragenyx Pharmaceutical, Inc.
Amphastar Pharmaceuticals, Inc.
Cerevel Therapeutics Holdings, Inc.
Akero Therapeutics, Inc.
MoonLake Immunotherapeutics
Bausch Health Cos., Inc.
Why is Amphastar Pharmaceuticals, Inc. ?
1
With a fall in PBT of -8.92%, the company declared Very Negative results in Jun 25
  • ROCE(HY) Lowest at 18.32%
  • RAW MATERIAL COST(Y) Grown by 6.41% (YoY)
  • INVENTORY TURNOVER RATIO(HY) Lowest at 2.39 times
2
Below par performance in long term as well as near term
  • Along with generating -32.83% returns in the last 1 year, the stock has also underperformed S&P 500 in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Amphastar Pharmaceuticals, Inc. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Amphastar Pharmaceuticals, Inc.
-32.47%
-0.85
42.61%
S&P 500
15.37%
0.56
19.88%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
16.69%
EBIT Growth (5y)
92.40%
EBIT to Interest (avg)
32.30
Debt to EBITDA (avg)
0.53
Net Debt to Equity (avg)
0.50
Sales to Capital Employed (avg)
0.56
Tax Ratio
18.02%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
80.55%
ROCE (avg)
18.59%
ROE (avg)
15.73%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
10
Industry P/E
Price to Book Value
1.91
EV to EBIT
9.28
EV to EBITDA
7.14
EV to Capital Employed
1.61
EV to Sales
2.47
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
17.33%
ROE (Latest)
19.18%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

1What is working for the Company
DEBT-EQUITY RATIO (HY)

Lowest at 55.62 %

-5What is not working for the Company
ROCE(HY)

Lowest at 18.32%

RAW MATERIAL COST(Y)

Grown by 6.41% (YoY

INVENTORY TURNOVER RATIO(HY)

Lowest at 2.39 times

DEBTORS TURNOVER RATIO(HY)

Lowest at 5.47 times

Here's what is working for Amphastar Pharmaceuticals, Inc.
Debt-Equity Ratio
Lowest at 55.62 %
in the last five Semi-Annual periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Depreciation
Highest at USD 16.24 MM
in the last five periods
MOJO Watch
The expenditure on assets done by the company may have gone into operation

Depreciation (USD MM)

Here's what is not working for Amphastar Pharmaceuticals, Inc.
Inventory Turnover Ratio
Lowest at 2.39 times
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Debtors Turnover Ratio
Lowest at 5.47 times
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Raw Material Cost
Grown by 6.41% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."